TruAlt Bioenergy Earnings Call Transcript: Key Takeaways
TruAlt Bioenergy reported massive YoY growth in Q1 FY27, driven by a strategic pivot to multi-feed ethanol operations and inventory of lower-cost maize.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
TruAlt Bioenergy reported massive YoY growth in Q1 FY27, driven by a strategic pivot to multi-feed ethanol operations and inventory of lower-cost maize.
TruAlt Bioenergy reported strong Q1FY27 consolidated performance with Total Income of ₹641.41 Cr, up 96.4% YoY. Strategy centers on dual-feed ethanol integration and expansion into CBG and SAF verticals.
TruAlt Bioenergy reported FY26 standalone revenue of ₹1,704cr (down from ₹1,880cr) due to low OMC tender allocations. EBITDA margin improved to 19.81%. Transitioning to a diversified biofuels platform.
TruAlt Bioenergy reported FY26 consolidated revenue of ₹1813.96 Cr and PAT of ₹96.87 Cr. The company is transitioning to a multi-feed, year-round ethanol platform.